RxDoctor Payments Data

Aaron Lewis

Optometrist · Enfield, CTNPI 1669090916

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.0% of the total across 246 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Among optometrist clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,213in general payments, 2019–2025

Across 246 payments — averaging $25.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$1K
  • Alcon$1K
  • Sun Pharmaceutical Industries Inc.$765
  • Coopervision Inc.$723
  • Novartis$437
  • Tarsus Pharmaceuticals, Inc.$402
  • plus $2K from 11 others

What the payments were for

  • Consulting fees$5008%
  • Food & beverage$5,71392%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,213 in reported general payments places this provider in the 95th percentile of 574 optometrist providers in Connecticut.

See all optometrist providers in Connecticut

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine24$35,294
XiidraLifitegrast15$28,493
MieboPerfluorohexyloctane/Pf16$12,186
TyrvayaVarenicline Tartrate12$8,029
Tobramycin-DexamethasoneTobramycin/Dexamethasone12$436
Latanoprost27$317
Timolol Maleate29$78

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bausch & Lomb Americas Inc.Xiidra, Miebo$1,278$40,67931 claims
AbbVieRestasis$248$35,29424 claims
Oyster Point Pharma, Inc.Tyrvaya$139$8,02912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 574 optometrist providers in Connecticut.

Other optometrist in Enfield

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →